HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prospective isolation of clonogenic mantle cell lymphoma-initiating cells.

Abstract
Here, we have prospectively isolated and characterized, for the first time, clonogenic cells with self-renewal capacities from mantle cell lymphoma (MCL), a particularly deadly form of non-Hodgkin's lymphoma (NHL). Self-renewal and tumorigenic activities were enriched in MCL cell fractions that lacked expression of the prototypic B-cell surface marker, CD19. CD45+CD19- cells represented a relatively small fraction of the total MCL tumor cells; however, they recapitulated the heterogeneity of original patient tumors on transplantation into immunodeficient mice. As few as 100 of these cells displayed self-renewal capacities in secondary and tertiary recipient mice by in vivo limiting dilution assays. Similar to leukemic stem cells, CD45+CD19- MCL cells also displayed a quiescent status as determined by dye efflux assays. In summary, this study is the first to isolate subpopulations of MCL cells that have self-renewal and tumorigenic capacities. Identification and characterization of MCL-ICs are important first steps toward understanding how self-renewal and tumorigenicity are regulated in MCL and designing targeted therapies against MCL-ICs will ultimately lead to improved outcomes for MCL patients.
AuthorsZheng Chen, Paul Ayala, Michael Wang, Luis Fayad, Ruth L Katz, Jorge Romaguera, Nancy Caraway, Sattva S Neelapu, Larry W Kwak, Paul J Simmons, Nami McCarty
JournalStem cell research (Stem Cell Res) Vol. 5 Issue 3 Pg. 212-25 (Nov 2010) ISSN: 1876-7753 [Electronic] England
PMID20851072 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2010 Elsevier B.V. All rights reserved.
Chemical References
  • Antigens, CD19
  • Leukocyte Common Antigens
Topics
  • Animals
  • Antigens, CD19 (metabolism)
  • Cell Separation
  • Humans
  • Leukocyte Common Antigens (metabolism)
  • Lymphoma, Mantle-Cell (metabolism, pathology)
  • Mice
  • Mice, SCID
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: